Reading this on a mobile device? Try our optimized mobile version here:

March 17, 2009
Apply now to present at the Business Forum at the 2009 BIO International Convention in Atlanta, May 18 to 21. The Business Forum is the biotech world's largest partnering event, attracting thousands of participants. Up to 250 companies will be selected to make presentations before audiences of BD professionals, CEOs and senior management of biotech and pharma companies, investors and academics.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
  • Cell Therapeutics examining strategic options
    Cell Therapeutics announced it is hiring a financial adviser to help evaluate "short- and long-term strategic business development opportunities and operational efficiencies" as the company struggles to sustain its operations. A spokesman for the biotech firm said the company intends to execute a reorganization plan that includes increasing focus on pixantrone, an experimental treatment for non-Hodgkin's lymphoma. The Seattle Times (3/16) LinkedInFacebookTwitterEmail this Story
 FREE REPORT – The Future of Biotech!
This comprehensive report into the future of our industry provides expert advice from some of the best minds in biotechnology. You'll see where our industry is headed – and what you can do to prepare yourself for that future. Published by BioWorld Today. Click here now to download your FREE report.

  Health Care in Transition 
  • Senate bipartisan group holds influence over health-reform plan
    The chance that a bill for comprehensive health care reform will be passed in Congress by the end of the year rests largely on a bipartisan group of nine senators that includes the chairmen of the Senate finance, health and budget committees. The group, led by Sen. Max Baucus, D-Mont., is tasked not only with crafting a bill that can win enough votes in the Senate but also managing turf wars between committees. Politico (Washington, D.C.) (3/16) LinkedInFacebookTwitterEmail this Story
  • Report: $19B in health IT funding to boost e-prescribing
    The $19 billion allocated in the economic-stimulus package for incentives to adopt health information technology will result in more than 75% of doctors using e-prescribing within five years and savings of $22 billion in drug and medical costs within 10 years, according to a study commissioned by the Pharmaceutical Care Management Association. The savings would offset money spent on the incentives and other health IT programs mandated in the stimulus, the study says. Government Health IT magazine (3/2009) LinkedInFacebookTwitterEmail this Story
  • Trial lawyers plan to oppose medical-malpractice reform
    Trial lawyers plan to fight the inclusion of any provision in a health care reform plan that will limit medical-malpractice suits, saying this will not help drive down health care costs. The American Medical Association, however, says medical-liability reforms are essential to the success of a reform measure. The debate could threaten President Barack Obama's goal of passing a health care reform bill by the end of the year. Politico (Washington, D.C.) (3/16) LinkedInFacebookTwitterEmail this Story
  Health Care & Policy 
  • Study: Test accurate in spotting early-stage Alzheimer's
    U.S. scientists found that a new test was 87% accurate in pinpointing whom among patients with early memory problems would likely develop Alzheimer's disease. The test works by quantifying the concentration of amyloid beta 42 polypeptide and the amount of the tau protein in spinal fluid. The technique will enable scientists to improve the clinical trials of Alzheimer's drugs, a researcher said. Yahoo!/Reuters (3/16) LinkedInFacebookTwitterEmail this Story
 Free Whitepaper: Enterprise Sales Contract Management for Life Sciences
Leading life sciences companies are recognizing the need for synchronized, enterprise-wide pricing and sales contract management processes. Learn more about how an integrated solution can provide the transparency needed to satisfy auditors, balance pricing with go-to-market strategies, and support sales and finance teams –including accurately predicting margins.

  Company & Financial News 
  • Cytos to cut jobs after vaccine fails in trial
    Cytos Biotechnology said it is eliminating 57 jobs to shift its financial resources to development projects and collaborative deals with Novartis AG and Pfizer. The move comes in the wake of a failed Phase II study of its hypertension vaccine CYT006-AngQb. Reuters (3/17) LinkedInFacebookTwitterEmail this Story
  • Other News
  Global Developments 

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or 

  Featured Content 

  Food & Agriculture 
  News from BIO 
  • Feeling the pinch in today's market hurts
    Let BIO ease your pain with BIO Business Solutions, BIO's cost-savings program, which provides products and services specific to the life sciences industry at discounted prices and other benefits. Participation is free to members of BIO and 38 state/regional biotech associations, and more than 1,900 companies currently use BIO Business Solutions. See how BIO Business Solutions can help your bottom line. Get more information about the 15 money-saving opportunities here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

It's no use boiling your cabbage twice."
--Irish proverb

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Executive:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Ashley McMaster
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
© 1999-2011 SmartBrief, Inc.® Legal Information